rs17373080

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000600355.5(NR1H2):​c.-127-452C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.293 in 152,252 control chromosomes in the GnomAD database, including 6,931 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6931 hom., cov: 33)
Exomes 𝑓: 0.27 ( 0 hom. )

Consequence

NR1H2
ENST00000600355.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.23

Publications

18 publications found
Variant links:
Genes affected
NR1H2 (HGNC:7965): (nuclear receptor subfamily 1 group H member 2) The liver X receptors, LXRA (NR1H3; MIM 602423) and LXRB, form a subfamily of the nuclear receptor superfamily and are key regulators of macrophage function, controlling transcriptional programs involved in lipid homeostasis and inflammation. The inducible LXRA is highly expressed in liver, adrenal gland, intestine, adipose tissue, macrophages, lung, and kidney, whereas LXRB is ubiquitously expressed. Ligand-activated LXRs form obligate heterodimers with retinoid X receptors (RXRs; see MIM 180245) and regulate expression of target genes containing LXR response elements (summary by Korf et al., 2009 [PubMed 19436111]).[supplied by OMIM, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 19-50376267-C-G is Benign according to our data. Variant chr19-50376267-C-G is described in ClinVar as Benign. ClinVar VariationId is 1263505.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.371 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000600355.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NR1H2
NM_007121.7
MANE Select
c.-437C>G
upstream_gene
N/ANP_009052.4P55055-1
NR1H2
NM_001256647.3
c.-437C>G
upstream_gene
N/ANP_001243576.2P55055-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NR1H2
ENST00000652203.1
c.-127-452C>G
intron
N/AENSP00000499121.1P55055-1
NR1H2
ENST00000939061.1
c.-127-452C>G
intron
N/AENSP00000609120.1
NR1H2
ENST00000939062.1
c.-127-452C>G
intron
N/AENSP00000609121.1

Frequencies

GnomAD3 genomes
AF:
0.293
AC:
44631
AN:
152112
Hom.:
6929
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.205
Gnomad AMI
AF:
0.377
Gnomad AMR
AF:
0.379
Gnomad ASJ
AF:
0.387
Gnomad EAS
AF:
0.162
Gnomad SAS
AF:
0.351
Gnomad FIN
AF:
0.296
Gnomad MID
AF:
0.350
Gnomad NFE
AF:
0.327
Gnomad OTH
AF:
0.299
GnomAD4 exome
AF:
0.273
AC:
6
AN:
22
Hom.:
0
Cov.:
0
AF XY:
0.250
AC XY:
3
AN XY:
12
show subpopulations
African (AFR)
AF:
0.500
AC:
1
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.500
AC:
2
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.250
AC:
3
AN:
12
Other (OTH)
AF:
0.00
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.558
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.293
AC:
44651
AN:
152230
Hom.:
6931
Cov.:
33
AF XY:
0.294
AC XY:
21853
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.205
AC:
8499
AN:
41548
American (AMR)
AF:
0.379
AC:
5794
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.387
AC:
1341
AN:
3466
East Asian (EAS)
AF:
0.162
AC:
840
AN:
5176
South Asian (SAS)
AF:
0.352
AC:
1699
AN:
4828
European-Finnish (FIN)
AF:
0.296
AC:
3133
AN:
10588
Middle Eastern (MID)
AF:
0.353
AC:
103
AN:
292
European-Non Finnish (NFE)
AF:
0.327
AC:
22274
AN:
68022
Other (OTH)
AF:
0.296
AC:
625
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1665
3329
4994
6658
8323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.309
Hom.:
938
Bravo
AF:
0.292
Asia WGS
AF:
0.247
AC:
858
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
5.9
DANN
Benign
0.66
PhyloP100
1.2
PromoterAI
0.00030
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17373080; hg19: chr19-50879524; API